Journal article
Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth
Breast cancer research and treatment, Vol.71(1), pp.47-57
01/2002
DOI: 10.1023/A:1013378113916
PMID: 11859873
Abstract
ErbB-3 (HER3) is a member of the epidermal growth factor receptor family. Increasing evidence suggests that elevated expression of ErbB-3 is important for malignancy. In this study, we found that elevated levels of ErbB-3 expression did not occur in the absence of AP-2gamma in a panel of human mammary epithelial and fibroblasts cell lines. In contrast, there was no association between the expression of AP-2alpha or AP-2beta and the level of ErbB-3, or between AP-2alpha and AP-2gamma double positivity and ErbB-3 expression. In co-transfection experiments, exogenous expression of AP-2gamma robustly activated ErbB-3 promoter activity. Moreover, expression of a dominant negative AP-2 protein, AP-2delta (deleted residues 31-117), not only repressed the ErbB-3 promoter activity but also suppressed endogenous ErbB-3 transcription in the ErbB-3 overexpressing cell line MRC-5VA. Overexpression of AP-2A resulted in a decreased proliferation rate and inhibitin of colony formation. Taken together, these data strongly support a role for the AP-2 gene family, in particular, AP-2gamma, in the control of ErbB-3 expression. Interference with the function of transcription factor AP-2 might provide a potential strategy for modulation of the malignant phenotype.
Details
- Title: Subtitle
- Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth
- Creators
- Chun-Hong Zhu - Free Radical & Radiation Biology Program, Department of Radiation Oncology, and Holden Comprehensive Cancer Center, The University of Iowa, Iowa City 52242, USAFrederick E Domann
- Resource Type
- Journal article
- Publication Details
- Breast cancer research and treatment, Vol.71(1), pp.47-57
- Publisher
- Netherlands
- DOI
- 10.1023/A:1013378113916
- PMID
- 11859873
- ISSN
- 0167-6806
- eISSN
- 1573-7217
- Grant note
- P01-CA-66081 / NCI NIH HHS CA-73612 / NCI NIH HHS
- Language
- English
- Date published
- 01/2002
- Academic Unit
- Pathology; Surgery; Radiation Oncology
- Record Identifier
- 9984046911902771
Metrics
20 Record Views